LCP-tacrolimus-induced Posterior Reversible Encephalopathy Syndrome in a High-immunological-risk Kidney Transplant Recipient
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Favi E, Spagnoletti G, Salerno M, Pedroso J, Romagnoli J, Citterio F
. Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. Clin Transplant. 2013; 27(4):E359-67.
DOI: 10.1111/ctr.12141.
View
2.
Jeelani H, Sharma A, Halawa A
. Posterior Reversible Encephalopathy Syndrome in Organ Transplantation. Exp Clin Transplant. 2022; 20(7):642-648.
DOI: 10.6002/ect.2021.0268.
View
3.
Parasher A, Jhamb R
. Posterior reversible encephalopathy syndrome (PRES): presentation, diagnosis and treatment. Postgrad Med J. 2020; 96(1140):623-628.
DOI: 10.1136/postgradmedj-2020-137706.
View
4.
Zhao B, Tang Y, Zhang B, Wu P, Li M, Xu X
. The Temperature-Dependent Retention of Introns in Transcripts Contributes to a Drooping and Fragile Shoot Phenotype in Rice. Int J Mol Sci. 2020; 21(1).
PMC: 6982220.
DOI: 10.3390/ijms21010299.
View
5.
Mahaparn I, Lepping R, Montgomery R, Mukherjee R, Billinger S, Brooks W
. The Association of Tacrolimus Formulation on Cerebral Blood Flow and Cognitive Function. Transplant Direct. 2023; 9(8):e1511.
PMC: 10348734.
DOI: 10.1097/TXD.0000000000001511.
View